awgldk
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Triples
Insights
Schema
BETA
Class frequency
Class hierarchy
SPARQL
GraphQL
BETA
Graphs
1
Q36833970-446FC65E-3A19-41E8-9ACB-734A369AAEC7
Q36833970-446FC65E-3A19-41E8-9ACB-734A369AAEC7
BestRank
Statement
http://www.wikidata.org/entity/statement/Q36833970-446FC65E-3A19-41E8-9ACB-734A369AAEC7
Comparison of erlotinib and pemetrexed as second-/third-line treatment for lung adenocarcinoma patients with asymptomatic brain metastases
P2860
Q36833970-446FC65E-3A19-41E8-9ACB-734A369AAEC7
BestRank
Statement
http://www.wikidata.org/entity/statement/Q36833970-446FC65E-3A19-41E8-9ACB-734A369AAEC7
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
d385d07a16c951ec9b71906bcc9691646989f062
P2860
High dose weekly erlotinib achieves therapeutic concentrations in CSF and is effective in leptomeningeal metastases from epidermal growth factor receptor mutant lung cancer.